Mapping the Target Localization and Biodistribution of Non-Radiolabeled VMAT2 Ligands in rat Brain
Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 3
Abstract
Imaging targeting vesicular monoamine transporter (VMAT2) alterations is a sensitive tool for early diagnosis of Parkinson’s disease. Our group has reported several novel 2-amino-DTBZ derivatives as potential VMAT2 imaging agents. The objective of this paper is to develop a non-radiolabeled methodology to screen the candidate compounds for accelerating the drug discovery process. 9-[18F]fluoropropyl-(+)-dihydrotetrabenazine ([18F]AV-133) is a PET imaging agent targeting VMAT2 binding sites in the brain. Nonradioactive AV-133 was injected (iv) into rats, at the end of the allotted time, the animals were killed and six regions of brain and plasma from each animal were processed for quantitative measurement of AV-133 by LC-MS/MS. These data were converted to the percentage injected dose per gram tissue weight (%ID/g tissue) and the brain target tissue to background ratios to allow direct comparison with data obtained by gamma counting of the injected radioactive [18F]AV-133. The %ID/g and the brain target tissue to background ratios calculated using the LC-MS/MS method were highly correlated to the values obtained by standard radioactivity measurements of [18F]AV-133. The pattern of AV-133 in rat brain was consistent with the known distribution of VMAT2. The concordance indicated that high-sensitivity LC-MS/MS is an indispensable tool in evaluating the quantity of administered chemical in tissue as part of the development of new molecular imaging probes. Furthermore, several novel 2-amino-DTBZ derivatives were detected using this methodology, and their biodistribution data in rat brain were obtained. The information about target engagements of candidates was provided.
Authors and Affiliations
Aifang Deng, Xianying Wu, Xue Zhou, Yan Zhang, Wei Yin, Jinping Qiao, Lin Zhu
Keywords
Related Articles
- EP ID EP681686
- DOI 10.1208/s12248-014-9584-9
- Views 96
- Downloads 0
Pulmonary Immunization of Guinea Pigs with Diphtheria CRM-197 Antigen as Nanoparticle Aggregate Dry Powders Enhance Local and Systemic Immune Responses
This study establishes the immune response elicited in guinea pigs after pulmonary and parenteral immunizations with diphtheria CRM-197 antigen (CrmAg). Several spray-dried powders of formalin-treated/untreated CrmAg nan...
Epigenetic Modifications of Nrf2 by 3,3′-diindolylmethane In Vitro in TRAMP C1 Cell Line and In Vivo TRAMP Prostate Tumors
The online version of this article (doi:10.1208/s12248-013-9493-3) contains supplementary material, which is available to authorized users.
Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson’s disease
Parkinson’s disease (PD) is a debilitating movement disorder resulting from a progressive degeneration of the nigrostriatal dopaminergic pathway and depletion of neurotransmitter dopamine in the striatum. Molecul...
Pediatric Biopharmaceutical Classification System: Using Age-Appropriate Initial Gastric Volume
The online version of this article (doi:10.1208/s12248-016-9885-2) contains supplementary material, which is available to authorized users.
Pharmacokinetics, mass balance, and tissue distribution of a novel DNA alkylating agent, VNP40101M, in rats
VNP40101M (1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(2 methylamino)carbonyl] hydrazine), a novel DNA alkylating agent, is currently under clinical development for the treatment of cancer in Phase I clinical trials. T...